Rob W. Armstrong
Directeur Général chez Artax Biopharma, Inc.
Profil
Rob W.
Armstrong is the founder of Boston Pharmaceuticals, Inc. He currently holds the position of Chief Executive Officer at Artax Biopharma, Inc. since 2024.
He is also currently serving as a Director at Cloud Pharmaceuticals, Inc. and Entrega, Inc. Additionally, he holds the position of Director at Curza Global LLC and President at Minden Exchange Bank & Trust Co. In his former positions, Armstrong worked as the Director-Small Molecule Drug Discovery at Amgen, Inc. from 1995 to 1999.
He also served as the Chief Business Officer at Gelesis, Inc. Furthermore, he was an Associate Professor at the University of California, Los Angeles and a Partner at Apple Tree Venture Management LLC.
Armstrong held the position of VP-Global External Research & Development at Lilly Research Laboratories from 1999 to 2011.
Armstrong obtained his doctorate degree from Colorado State University in 1984.
He completed his undergraduate studies at the University of California San Diego in 1979.
Postes actifs de Rob W. Armstrong
| Sociétés | Poste | Début |
|---|---|---|
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Directeur Général | 04/01/2024 |
Cloud Pharmaceuticals, Inc.
 Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | Directeur/Membre du Conseil | 01/01/2013 |
Entrega, Inc.
 Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 01/01/2013 |
Curza Global LLC
 Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - |
Minden Exchange Bank & Trust Co.
 Minden Exchange Bank & Trust Co. Regional BanksFinance Minden Exchange Bank & Trust Co. operates as a state chartered commercial bank. Its services include automated teller machine and debit cards, online and mobile banking, exchange bill pay, trust services, direct deposit, notary services, night deposit, coin counting, wire, automatic and telephone transfers, and cashiers check. It offers checking, savings, money market, loans, certificates of deposit, and individual retirement account. The company was founded in September 1, 1883 and is headquartered in Minden, NE. | President | - |
Anciens postes connus de Rob W. Armstrong
| Sociétés | Poste | Fin |
|---|---|---|
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Directeur Technique/Scientifique/R&D | 28/02/2011 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/1999 |
| University of California, Los Angeles | Corporate Officer/Principal | 01/01/1995 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Fondateur | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Rob W. Armstrong
| Colorado State University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | Health Technology |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Minden Exchange Bank & Trust Co.
Minden Exchange Bank & Trust Co. Regional BanksFinance Minden Exchange Bank & Trust Co. operates as a state chartered commercial bank. Its services include automated teller machine and debit cards, online and mobile banking, exchange bill pay, trust services, direct deposit, notary services, night deposit, coin counting, wire, automatic and telephone transfers, and cashiers check. It offers checking, savings, money market, loans, certificates of deposit, and individual retirement account. The company was founded in September 1, 1883 and is headquartered in Minden, NE. | Finance |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | Health Technology |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | Health Technology |
